Vapocoolant (Pain Ease Medium Stream) for Intravenous Lines in Emergency Department Patients
Status: | Completed |
---|---|
Conditions: | Chronic Pain, Hospital |
Therapuetic Areas: | Musculoskeletal, Other |
Healthy: | No |
Age Range: | 18 - 80 |
Updated: | 2/7/2015 |
Start Date: | October 2012 |
End Date: | December 2014 |
Contact: | Sharon A. O'Keefe, RN/BSN |
Email: | okeefes@ccf.org |
Phone: | 1-800-223-2273 |
Prospective,Randomized,Blinded, Comparative,Efficacy and Safety Trial of Vapocoolant (Pain Ease Medium Stream) for Intravenous Cannulation in Emergency Department Patients.
To determine the efficacy and safety of vapocoolant stream (Pain Ease Medium Stream ) in
decreasing the pain of intravenous cannulation.
To compare vapocoolant stream (Pain Ease medium Stream) with control (e.g. sterile water)
stream.
decreasing the pain of intravenous cannulation.
To compare vapocoolant stream (Pain Ease medium Stream) with control (e.g. sterile water)
stream.
Vapocoolant sprays have been used to decrease the pain associated with painful medical
procedures such as immunizations, needle aspirations, injections, venipuncture and
intravenous cannulation. In general, vapocoolant sprays , have been found to be effective
in decreasing the pain of various medical procedures. Moreover, the use of vapocoolant
sprays ,unlike other local anesthetics , such as infiltrative lidocaine , is not associated
with a painful injection and does affect the success rate of the procedure including
intravenous cannulation and may even increase the success rate of the intravenous
cannulation.
procedures such as immunizations, needle aspirations, injections, venipuncture and
intravenous cannulation. In general, vapocoolant sprays , have been found to be effective
in decreasing the pain of various medical procedures. Moreover, the use of vapocoolant
sprays ,unlike other local anesthetics , such as infiltrative lidocaine , is not associated
with a painful injection and does affect the success rate of the procedure including
intravenous cannulation and may even increase the success rate of the intravenous
cannulation.
Inclusion Criteria:
- Patients needing intravenous cannulation
- Adults age 18 years equal or greater than.
- Stable patient
- Mentally competent patient able to understand the consent form
Exclusion Criteria:
- Patients with any allergies to the spray components ( e.g.1,1,3,3,
pentafluoropropane or 1,1,1,2 tetrafluoroethane )
- Critically ill or unstable patient (e.g. sepsis or shock)
- Infants and children of age , <18 years.
- Pregnant
- Intravenous cannulation site located in area of compromised blood supply. (ex:
patients with Peripheral Vascular Disease , Raynaud's disease, gangrene, Buerger's
disease)
- Intravenous cannulation site located in area of insensitive skin; such as , patients
with a peripheral neuropathy including diabetic neuropathy.
- Patient intolerant of cold or with hypersensitivity to the cold.
- Patient unable or unwilling to give consent.
We found this trial at
1
site
Cleveland Clinic Cleveland Clinic is committed to principles as presented in the United Nations Global...
Click here to add this to my saved trials